{
    "ticker": "BLRX",
    "name": "BioLineRx Ltd.",
    "description": "BioLineRx Ltd. is a clinical-stage biopharmaceutical company focused on the development of innovative therapies for cancer and other serious diseases. Founded in 2003 and headquartered in Jerusalem, Israel, BioLineRx specializes in the development of proprietary drug candidates based on its unique platform technologies. The company\u2019s lead product candidate, BL-8040, is a novel drug designed to mobilize stem cells and enhance immune responses in various cancers, including acute myeloid leukemia (AML) and pancreatic cancer. BioLineRx is committed to improving patient outcomes through targeted therapies and is actively engaged in clinical trials to assess the efficacy and safety of its product candidates. With a strong emphasis on research and development, the company collaborates with leading academic institutions and research organizations to advance its pipeline. BioLineRx aims to address unmet medical needs and is dedicated to bringing transformative therapies to market, thereby contributing to the advancement of oncology treatments globally.",
    "industry": [
        "Biopharmaceutical",
        "Healthcare"
    ],
    "headquarters": "Jerusalem, Israel",
    "founded": "2003",
    "website": "https://www.biolinerx.com",
    "ceo": "Philip Serlin",
    "social_media": {
        "twitter": "https://twitter.com/BioLineRx",
        "linkedin": "https://www.linkedin.com/company/biolinerx/"
    },
    "investor_relations": "https://www.biolinerx.com/investors",
    "key_executives": [
        {
            "name": "Philip Serlin",
            "position": "CEO"
        },
        {
            "name": "David E. R. S. Kauffman",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Oncology",
            "products": [
                "BL-8040",
                "BL-7010"
            ]
        }
    ],
    "seo": {
        "meta_title": "BioLineRx Ltd. | Innovative Therapies for Cancer",
        "meta_description": "Discover BioLineRx Ltd., a clinical-stage biopharmaceutical company focused on developing innovative therapies for cancer and other serious diseases. Explore BioLineRx's leading products and commitment to advancing oncology treatments.",
        "keywords": [
            "BioLineRx",
            "Biopharmaceutical",
            "Oncology",
            "Cancer Treatment",
            "BL-8040",
            "Clinical Trials"
        ]
    },
    "faq": [
        {
            "question": "What is BioLineRx known for?",
            "answer": "BioLineRx is known for its innovative therapies for cancer and other serious diseases, particularly its lead product candidate BL-8040."
        },
        {
            "question": "Who is the CEO of BioLineRx?",
            "answer": "Philip Serlin is the CEO of BioLineRx Ltd."
        },
        {
            "question": "Where is BioLineRx headquartered?",
            "answer": "BioLineRx is headquartered in Jerusalem, Israel."
        },
        {
            "question": "What are BioLineRx's main products?",
            "answer": "BioLineRx's main products include BL-8040 and BL-7010, which are in various stages of clinical development."
        },
        {
            "question": "When was BioLineRx founded?",
            "answer": "BioLineRx was founded in 2003."
        }
    ],
    "competitors": [
        "IMGN",
        "CRMD",
        "NVS",
        "RHHBY"
    ],
    "related_stocks": [
        "AAPL",
        "AMGN",
        "GILD",
        "JNJ"
    ]
}